Currency in SEK
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.96 | 1.02 | 3.96 | 4.39 |
| Low estimate | 0.9 | 1 | 3.94 | 4.33 |
| High estimate | 1.02 | 1.05 | 3.99 | 4.45 |
| Year ago EPS | 1.15 | 0.8 | 3.62 | 3.96 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 334.5M | 362M | 1.4B | 1.57B |
| Low estimate | 327M | 355M | 1.39B | 1.56B |
| High estimate | 342M | 369M | 1.42B | 1.58B |
| Year ago sales | 365.82M | 315.22M | 1.3B | 1.4B |
| Sales growth (year/est) | -8.60% | 14.80% | 8.30% | 11.70% |
| Earnings history | 31/03/2023 | 30/06/2023 | 30/09/2023 | 31/12/2023 |
|---|
| Est. EPS | 0.88 | 0.74 | 0.78 | 0.59 |
| Actual EPS | 1.15 | 0.8 | 1.01 | 0.67 |
| Difference | 0.27 | 0.06 | 0.23 | 0.08 |
| Surprise % | 30.70% | 8.10% | 29.50% | 13.60% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0.96 | 1.02 | 3.96 | 4.39 |
| 7 days ago | 0.96 | 1.02 | 3.96 | 4.39 |
| 30 days ago | 1.12 | 0.89 | 3.98 | 4.41 |
| 60 days ago | 1.12 | 0.89 | 3.98 | 4.41 |
| 90 days ago | 1.47 | 0.88 | 4.04 | 4.49 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | 1 | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | BIOG-B.ST | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | -16.50% | N/A | N/A | N/A |
| Next qtr. | 27.50% | N/A | N/A | N/A |
| Current year | 9.40% | N/A | N/A | N/A |
| Next year | 10.90% | N/A | N/A | N/A |
| Next 5 years (per annum) | 16.50% | N/A | N/A | N/A |
| Past 5 years (per annum) | 12.72% | N/A | N/A | N/A |
